Tissue is a cluster or layer of cells which accomplishes particular function and contains necessary genetic and biological information. Tissue samples are used for cancer analysis, where it captures the biological background of the syndrome. It imitates the presence of cancer by inspecting the tissue sample under microscope by a skilled physician also known as pathologist. Histopathology is a study of syndrome in a tissue which can be cured by small surgeries and open biopsy or surgery. The three major types of tissue diagnosis are Immunohistochemistry (IHC), Hematoxylin and Eosin (H&E), and In situ hybridization. Hence, many kinds of cancer can be cured by using these technologies like breast cancer, gastric cancer, lymphoma, prostate cancer and others.

Market Dynamics

Factor driving the growth of tissue diagnostics market includes improving infrastructure for cancer diagnosis, growing healthcare expenditure, rising incidences of cancer, and technological development and advancements in tissue diagnostics. When compared developing countries to developed countries, there is low health issue awareness due to some factors like low literacy rate, economic factors, etc. which adversely affects the growth of this market in developing countries. Technological development, mandate for better and advanced treatment can boost the growth of this market in near future.

Market Classification

The market can be bifurcated on the basis of product, technology, disease, end user, and geography. By product, tissue diagnostics market can be segmented into consumables and instruments. Consumables can be further bifurcated into antibodies, kits, reagents, probes and instruments are further classified into slide-staining systems, scanners, tissue-processing systems, and others. By technology, tissue diagnostics market can be segmented into in special staining situ hybridization, workflow management immunohistochemistry, and digital pathology. By disease, tissue diagnostics market can be segmented into gastric cancer, breast cancer, lymphoma, non-small cell lung cancer, prostate cancer, and other diseases. By end user, tissue diagnostics market can be segmented intohospitals, pharmaceutical companies, research laboratories, contract research organizations, and among other end users. On the basis of geography, the tissue diagnostics market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific.

Report Coverage

Market Participants

Some of the major players involved in tissue diagnostics market include F. Hoffmann-La Roche AG, The Danaher Corporation, Thermo Fisher Scientific, Abbott  Laboratories, Agilent Technologies, Sakura Finetek Japan Co., Ltd., Sienna Cancer Diagnostics, Royal Philips N.V., A. Menarini Diagnostics Ltd., Cell Signaling Technology, Enzo Life Sciences, Inc., Master Diagnostica S.L., and TissueGnostics among others.

Market Segmentation

Market By Product

• Consumables
  • Antibodies
  • Kits
  • Reagents
  • Probes
• Instruments
  • Slide-staining Systems
  • Scanners
  • Tissue-processing Systems
  • Others

Market By Technology

• Immunohistochemistry
• In Situ Hybridization
• Digital Pathology and Workflow Management
• Special Staining

Market By Disease

• Breast Cancer
• Gastric Cancer
• Lymphoma
• Prostate Cancer
• Non-small Cell Lung Cancer
• Others

Market By End User

• Hospitals
• Pharmaceutical Companies
• Research Laboratories
• Contract Research Organizations
• Others

Market By Geography

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • France
  • Germany
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Chile
  • Rest of LATAM
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Rest of MEA